6:18 PM
 | 
Jan 29, 2014
 |  BC Extra  |  Top Story

Dicerna, Celladon price IPOs

RNAi play Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) and gene therapy company Celladon Corp. (NASDAQ:CLDN) both raised money in IPOs on Wednesday. Dicerna raised $90 million through the sale of 6 million shares at $15, which values the company at $249.4 million. Dicerna set the terms for the...

Read the full 216 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >